NCT02616302 / 2014-004506-15: A Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children |
|
|
| Recruiting | 2 | 70 | Europe, Canada, US, RoW | Dexlansoprazole, Dexilant | Takeda | Gastroesophageal Reflux Disease (GERD) | 01/25 | 01/25 | | |
BABE, NCT04877834: Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. |
|
|
| Completed | 1 | 60 | RoW | Dexlansoprazole, DelanzoTMDR 60 mg capsule, hard, Dexilant® 60 mg capsule, hard | University of Karachi, SAMI Pharmaceutical, Karachi Pakistan | Healthy, Bioequivalence Study | 10/22 | 11/22 | | |